The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes.

2018

Sir Jules Thorn Trust Swiss National Science Foundation, Wellcome Trust JDRF, NIHR Cambridge Biomedical Research Centre.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

30

References

11

Citations